Chugai Pharmaceutical Co., Ltd.
CHGCF
$42.03
-$1.06-2.45%
OTC PK
| 06/30/2025 | 06/30/2025 | 03/31/2025 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -205.52% | -205.52% | 6.27% | -- | -- |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 47.44% | 47.44% | 46.50% | 102.26% | -51.93% |
| Change in Net Operating Assets | 553.88% | 553.88% | -75.10% | -53.24% | 168.45% |
| Cash from Operations | 88.96% | 88.96% | -56.22% | -33.32% | -19.22% |
| Capital Expenditure | -28.06% | -28.06% | -11,500.25% | -57.69% | 30.85% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -19.30% | -100.54% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 55.84% | 55.84% | -290.85% | -478.16% | -423.15% |
| Cash from Investing | 43.43% | 43.43% | -414.39% | -315.41% | -668.07% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 200.00% | 200.00% | -133.39% | -- | -- |
| Issuance of Common Stock | -90.43% | -90.43% | 618.75% | -74.67% | 50.00% |
| Repurchase of Common Stock | 0.00% | 0.00% | 0.00% | 33.33% | -50.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 99.51% | 99.51% | -32,132.10% | 99.21% | -17,452.18% |
| Other Financing Activities | -7,880.39% | -7,880.39% | 99.35% | -4.54% | -0.20% |
| Cash from Financing | 97.27% | 97.27% | -4,599.40% | 96.30% | -2,791.04% |
| Foreign Exchange rate Adjustments | 392.02% | 392.02% | -142.97% | 39.13% | 1,180.66% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -291.04% | 198.53% |
| Net Change in Cash | 166.56% | 166.56% | -185.78% | -1,671.01% | -96.73% |